Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 1503 Results Clear All
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Marson Lab Genomic Immunology Cancer Autoimmune Diseases News Release
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for designing cancer immunotherapies and treating autoimmune conditions.
Quantitative Biosciences Institute—A group of scientists, led by Gladstone Investigator Nevan Krogan, studied 100 autism risk genes and found that many patient-derived mutations disrupt core biological processes—a discovery that opens new avenues for future interventions.
Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.
Alexanian Lab Cardiovascular Disease Human Genetics Grants Congenital Heart Disease
Meet Lexi Schneider, a PhD student using innovative technology to better understand the blood brain barrier.
Profile Graduate Students and Postdocs Yang Lab
TIME—Gladstone Investigator Shinya Yamanaka reflects on the past 20 years since his groundbreaking discovery of iPS cells and its potential to transform human health.
Yamanaka Lab Stem Cells/iPSCs iPS Cell Research Center
Parker Institute for Cancer Immunotherapy—Five investigators, including Jingya Qiu, will receive more than $1 million in combined funding to advance research projects that will accelerate the development of next-generation immunotherapies for cancer patients.
Cancer Parker Institute for Cancer Immunotherapy
Nature—20 years after his discovery of iPS cells, Gladstone Investigator Shinya Yamanaka comments on the field’s progress toward clinical therapies.
Yamanaka Lab Stem Cells/iPSCs
New York Times—Gladstone Investigator Lennart Mucke comments on the connection between epilepsy and dementia, noting that some dementia-like symptoms may be caused by epileptic activity and resolve with treatment. (Subscription required.)
Mucke Lab Alzheimer’s Disease Epilepsy Neurological Disease
Nature—Gladstone Investigator Shinya Yamanaka reflects on the 20th anniversary of the discovery of iPS cells and the field’s progress toward clinical therapies.
Yamanaka Lab Stem Cells/iPSCs
Gladstone and UCSF scientists developed a method to genetically edit myeloid cells, immune cells that act as the body’s first responders.
News Release Marson Lab Carnevale Lab Cancer Genomic Immunology CRISPR/Gene Editing
A new screening platform uncovers gene edits that enhance CAR-T cells’ ability to infiltrate and eliminate solid tumors.
News Release Carnevale Lab Cancer Genomic Immunology CRISPR/Gene Editing
Scientists from across the NOMIS community gathered in Switzerland for the inaugural NOMIS Fellows Symposium.
NOMIS Neurological Disease Mucke Lab
ScholarPeer—Gladstone Investigators Deepak Srivastava and Lana Zholudeva led a study showing that human stem cell-derived neurons can integrate into damaged spinal cords and improve breathing in injured rats—an encouraging step toward cell-based treatments for spinal cord injuries.
Spinal Cord Injuries Srivastava Lab
The Stem Cell Podcast—Gladstone Investigator Shinya Yamanaka discusses how his lab is advancing iPSC therapies toward the clinic while continuing to investigate the basic mechanisms underlying pluripotency, stem cell biology, and translation initiation.
Yamanaka Lab Stem Cells/iPSCs
